Browse > Article
http://dx.doi.org/10.4070/kcj.2011.41.8.434

Comparison of Recurrence Rate Based on the Frequency of Preceding Symptoms in Patients With Neurocardiogenic Syncope or Presyncope  

Lee, Seon-Mee (Division of Cardiology, Department of Medicine, Sam Anyang General Hospital)
Oh, Hye-Lim (Division of Cardiology, Department of Medicine, Sam Anyang General Hospital)
Kim, June-Soo (Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Park, Jung-Wae (Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Yim, Hye-Ran (Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Shin, Dae-Hee (Division of Cardiology, Gangneung Asan Hospital, University of Ulsan College of Medicine)
On, Young-Keun (Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Sang-Hoon (Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
Korean Circulation Journal / v.41, no.8, 2011 , pp. 434-439 More about this Journal
Abstract
Background and Objectives: In patients with neurocardiogenic syncope or presyncope, symptoms developed unpredictably and intermittently. The purpose of this study was to determine whether there was any significant difference in the recurrence rate of symptoms during the follow-up period between patients with many episodes of symptoms and those with fewer episodes of symptoms before diagnosis, as well as to assess the clinical significance of previous episodes of symptoms during treatment. Subjects and Methods: A total of 100 patients with neurocardiogenic syncope or presyncope were divided in two groups (high episode group, n=54; low episode group, n=46) according to the frequency of symptoms before the head-up tilt test. We retrospectively analyzed the recurrence of symptoms using telephone interviews and medical record reviews. Results: The clinical characteristics were not significantly different between the two groups. However, the recurrence rate was significantly lower in the high episode group than in the low episode group (5.6% vs. 19.6%, p=0.001). In the high episode group, patients treated with medication showed higher recurrence of symptoms than those without medication. In the lower episode group, a similar result was observed. Conclusion: The frequency of previous symptoms at the diagnosis of neurocardiogenic syncope or presyncope did not predict the occurrence of symptoms during the follow-up period. Therefore, to continue drug treatment based on the frequency of symptoms in patients with neurocardiogenic syncope or presyncope may not be the best option.
Keywords
Neurocardiogenic syncope; Syncope, vasovagal; Recurrence;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Abboud FM. Neurocardiogenic syncope. N Engl J Med 1993;328: 1117-20.   DOI   ScienceOn
2 Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. Pacing Clin Electrophysiol 1995;18:716-24.   DOI   ScienceOn
3 Youn HJ, Chung WS, Back SH, et al. The usefullness of head-up tilt test in the diagnosis of syncope of unknown origin and clinical characteristics of the patients with vasovagal syncope. Korean J Med 1994;47:186-94.
4 Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope: American College of Cardiology. J Am Coll Cardiol 1996;28:263-75.   DOI   ScienceOn
5 Oh JH, Kim JS, Kwon HC, et al. Predictors of positive head-up tilt test in patients with suspected neurocardiogenic syncope or presyncope. Pacing Clin Electrophysiol 2003;26:593-8.   DOI   ScienceOn
6 Ruiz GA, Peralta A, Gonzalez-Zuelgaray J, Duce E. Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment. Am Heart J 1995;130:345-50.   DOI   ScienceOn
7 Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996;93:973-81.   DOI   ScienceOn
8 Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J 1991;122:1644-51.   DOI   ScienceOn
9 Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induc-ed neurally mediated syncope. Am J Cardiol 1992;70:339-42.   DOI   ScienceOn
10 Natale A, Sra J, Dhala A, et al. Efficacy of different treatment strategies for neurocardiogenic syncope. Pacing Clin Electrophysiol 1995;18:655-62.   DOI   ScienceOn
11 Cox MM, Perlman BA, Mayor MR, et al. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995;26:1293-8.   DOI   ScienceOn
12 Ahn SJ, Kim JS, Ha KW, et al. Long-term follow-up in patients with neurocardiogenic syncope with or without therapy. Korean Circ J 1998;28:1502-8.   DOI
13 Kouakam C, Vaksmann G, Pachy E, Lacroix D, Rey C, Kacet S. Long-term follow-up of children and adolescents with syncope: predictor of syncope recurrence. Eur Heart J 2001;22:1618-25.   DOI   ScienceOn
14 Baron-Esquivias G, Errazquin F, Pedrote A, et al. Long-term outcome of patients with vasovagal syncope. Am Heart J 2004;147:883-9.   DOI   ScienceOn
15 Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of atenolol for prevention of neurally mediated syncope in a highly symptomatic po-pulation: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37:554-9.   DOI   ScienceOn
16 Sheldon R, Connolly S, Rose S, et al. Prevention of syncope trial (PO-ST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006;113:1164-70.   DOI   ScienceOn
17 Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-con-trolled, randomized trial. J Am Coll Cardiol 2005;45:484-8.   DOI   ScienceOn
18 Raviele A, Brignole M, Sutton R, et al. Effects of etilefrine in prevent-ing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial: the Vasovagal Syncope International Study. Circulation 1999;99:1452-7.   DOI   ScienceOn
19 Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neurally mediat-ed syncope: a double-blind, randomized, crossover study. Ann Neurol 2002;52:342-5.   DOI   ScienceOn
20 Takata TS, Wasmund SL, Smith ML, et al. Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 2002;106:1500-4.   DOI   ScienceOn
21 Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.   DOI   ScienceOn